Chronic oral graft-versus-host disease (cGVHD) is a complex, frequent, and highly impactful
complication of allogeneic hematopoietic cell transplantation (alloHCT). It represents the …

Chronic graft-versus-host disease (cGVHD) is a multi-organ disease that occurs post-
hematopoietic stem cell transplantation, with the mouth being one of the most frequently …

Chronic graft-versus-host disease (cGVHD) after allogeneic hematopoietic stem cell
transplantation is still associated with significant morbidity and mortality. First-line treatment …

Chronic graft-versus-host disease (cGVHD) is a major complication of allogeneic
hematopoietic cell transplantation that is associated with a diminished quality of life. The oral …

A joint working group established by the Haemato‐oncology subgroup of the British
Committee for Standards in Haematology and the British Society for Bone Marrow …

Allogeneic hematopoietic cell transplantation (allo-HCT) is considered to be a curative
treatment of many hematologic malignancies as well as for a wide range of hematologic and …

Introduction The field of allogeneic hematopoietic cell transplantation (allo‐HCT) began in
the 1950s, and despite a seven decade history of remarkable clinical advances, graft‐versus …

Chronic Graft-versus-Host Disease (cGVHD) is a major long-term complication, associated
with morbidity and mortality in patients following allogenic hematopoietic cell transplantation …

Introduction: The oral mucosa is commonly involved in chronic graft-versus-host disease
(cGVHD). Oral mucosal cGVHD markedly affect individual's daily function and wellbeing. In …

Patients who undergo allogeneic stem cell transplantation frequently develop an
immunologic disease caused by the reactivation of the graft to the host tissues. This disease …